agmatine has been researched along with Dyskinesia, Drug-Induced in 2 studies
Agmatine: Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of agmatine in preclinical behavioral tests of schizophrenia has been examined in rodents." | 7.78 | Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents. ( Chopde, CT; Gawande, DY; Hadole, PN; Kotagale, NR; Mendhi, SM; Palhade, MW; Taksande, BG; Wadhwani, PJ, 2012) |
| "The effect of agmatine in preclinical behavioral tests of schizophrenia has been examined in rodents." | 3.78 | Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents. ( Chopde, CT; Gawande, DY; Hadole, PN; Kotagale, NR; Mendhi, SM; Palhade, MW; Taksande, BG; Wadhwani, PJ, 2012) |
| "Agmatine is an endogenous arginine metabolite that emerges as neuromodulator and a promising agent to manage diverse central nervous system disorders by modulating nitric oxide (NO) pathway, glutamate NMDA receptors and oxidative stress." | 1.43 | Agmatine attenuates reserpine-induced oral dyskinesia in mice: Role of oxidative stress, nitric oxide and glutamate NMDA receptors. ( Blum-Silva, CH; Colle, D; Cunha, AS; Cunha, MP; Farina, M; Matheus, FC; Moretti, M; Poli, A; Prediger, RD; Reginatto, FH; Rodrigues, AL; Sampaio, TB; Sandjo, LP; Santos, DB, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunha, AS | 1 |
| Matheus, FC | 1 |
| Moretti, M | 1 |
| Sampaio, TB | 1 |
| Poli, A | 1 |
| Santos, DB | 1 |
| Colle, D | 1 |
| Cunha, MP | 1 |
| Blum-Silva, CH | 1 |
| Sandjo, LP | 1 |
| Reginatto, FH | 1 |
| Rodrigues, AL | 1 |
| Farina, M | 1 |
| Prediger, RD | 1 |
| Kotagale, NR | 1 |
| Taksande, BG | 1 |
| Wadhwani, PJ | 1 |
| Palhade, MW | 1 |
| Mendhi, SM | 1 |
| Gawande, DY | 1 |
| Hadole, PN | 1 |
| Chopde, CT | 1 |
2 other studies available for agmatine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Agmatine attenuates reserpine-induced oral dyskinesia in mice: Role of oxidative stress, nitric oxide and glutamate NMDA receptors.
Topics: Agmatine; Animals; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Do | 2016 |
Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents.
Topics: Agmatine; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Catalepsy; Disease Mo | 2012 |